Molecular Genetics & Genomic Medicine (Nov 2023)

Identification of a de novo variant in the ASXL2 gene related to Shashi‐Pena syndrome

  • Yanyan Zheng,
  • Le Yang,
  • Mengmeng Niu,
  • Siyu Zhao,
  • Lili Liang,
  • Yan Wu,
  • Taoli Li,
  • Fan Yang,
  • Zuozhen Yang,
  • Yan Wang,
  • Dong Wang

DOI
https://doi.org/10.1002/mgg3.2251
Journal volume & issue
Vol. 11, no. 11
pp. n/a – n/a

Abstract

Read online

Abstract Background ASXL2 encodes proteins involved in epigenetic regulation and the assembly of transcription factors at specific genomic loci. Germline de novo truncating variants in ASXL2 have been implicated in Shashi‐Pena syndrome, which results in features of developmental delay (DD), glabellar nevus flammeus, hypotonia, and cardiac disorders. However, the variants are rare, and the clinical spectrum may be incomplete. Methods The clinical data such as brain MRI were collect. The whole exome sequencing was performed for genetic etiology analysis. Results Here, we report a patient with DD, hypotonia, early atrial septal defect, and abnormal white matter signal. She presented with Shashi–Pena syndrome with a truncated variant in ASXL2 (NM_018263.6, c.2142_2152del, p.Ser714Argfs*5). She died of a digestive tract infection when she was 1 year and 6 months old. Conclusions Our study further expanded the spectrum of phenotypes and genetic variations of the syndrome, and we believe that it is necessary to screen the ASXL2 gene in patients with DD and cardiac and bone disorders.

Keywords